Specialized in the field of hemostasis, Cryopep offers a new alternative to traditional lyophilized reagents by offering medical biology laboratories an innovative range of ready-to-use reagents. The company is based in Montpellier (34) in the heart of a business village and benefits from this dynamic to carry out all of its activities. Since its creation in 2008, the development of the company has accelerated and Cryopep’s activities today cover French territory and certain European countries. The growth experienced by the company is mainly due to the commercialization of reagents and frozen plasmas for diagnostic and research uses. The company is in compliance with the regulations in force (CE and FDA marking, ISO 9001: 2015 standard, ISO 13485: 2016 standard). The Cryopep company, through its know-how and innovation, is an essential partner in the exploration of diseases of hemostasis, thrombosis and auto-immunity.